Alnylam Pharmaceuticals (ALNY) P/E US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| P/E | ? | -23.6 | -25.6 | -54.3 | -108.0 | 166.0 | 66.9 | |
| Changes by years, y/y, % | +35% | +9% | +112% | +99% | -254% | |||
Alnylam Pharmaceuticals. P/E
Alnylam Pharmaceuticals. P/E, changes, %
Alnylam Pharmaceuticals (ALNY) P/E US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/E | ? | -129.8 | -132.5 | 1 376 | 167.6 | 76.2 | 66.9 | |
| Changes by years, y/y, % | +129% | -69% | -1 393% | -254% | -159% | |||
| Changes by quarters, q/q, % | +19% | +2% | -1 138% | -88% | -55% | |||